Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-12-15

Clinical Trial Update: Comparing Consistency of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold for Latent Tuberculosis in Dialysis Population

View source ↗

Summary

The trial assesses the agreement between QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold for detecting latent tuberculosis infection in patients undergoing dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QuantiFERON-TB Gold (Interferon-gamma release assay (IGRA) for latent TB)
  • QuantiFERON-TB Gold Plus (Interferon-gamma release assay)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Patients on Dialysis | Status: UNKNOWN